UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 低リン血症の原因causes of hypophosphatemia [show details]
…urinary phosphate excretion; Removal by renal replacement therapies; The causes of hypophosphatemia will be reviewed here. The diagnosis and treatment of hypophosphatemia are discussed separately. Stimulation …
2. 低リン血症の評価および治療evaluation and treatment of hypophosphatemia [show details]
…with hypophosphatemia: A 24-hour urine phosphate excretion less than 100 mg or a FEPO4 less than 5 percent indicates appropriate low renal phosphate excretion, suggesting that the hypophosphatemia is caused …
3. 低リン血症の徴候および症状signs and symptoms of hypophosphatemia [show details]
…Significant hypophosphatemia is also observed in patients receiving continuous renal replacement therapies, yet the clinical relevance of this finding remains uncertain. Severe hypophosphatemia can also …
4. アルコール中毒患者における低リン血症hypophosphatemia in the alcoholic patient [show details]
… mg/kg (0.48 to 0.64 mmol/kg) per day. This dose is lower than that given to patients with hypophosphatemia due to renal phosphate wasting in whom raising the serum phosphate will increase phosphate excretion …
5. 末期腎不全患者の副甲状腺摘出後に生じる飢餓骨症候群hungry bone syndrome following parathyroidectomy in end stage renal disease patients [show details]
… phosphate loss in the urine. Clinically significant hypomagnesemia and hypophosphatemia are uncommon in patients with chronic renal failure undergoing parathyroidectomy. Serum phosphate values are typically …

English Journal

Phosphate supplementation for hypophosphatemia during continuous renal replacement therapy in adults.

Song YH, Seo EH, Yoo YS, Jo YI.
Renal failure. 2019 Nov;41(1)72-79.
Hypophosphatemia is common during continuous renal replacement therapy (CRRT) in critically ill patients and can cause generalized muscle weakness, prolonged respiratory failure, and myocardial dysfunction. This study aimed to investigate the efficacy and safety of adding phosphate to the dialysate
PMID 30909778

Fluconazole as a New Therapeutic Tool to Manage Patients With NPTIIc (SLC34A3) Mutation: A Case Report.

Bertholet-Thomas A, Tram N, Dubourg L, Lemoine S, Molin A, Bacchetta J.
American journal of kidney diseases : the official journal of the National Kidney Foundation. 2019 Jun;73(6)886-889.
Mutations in the SLC34A3 gene, encoding the sodium/phosphate cotransporter 2C (NPTIIc), induce decreased renal phosphate reabsorption, hypophosphatemia, decreased fibroblast growth factor 23 and parathyroid hormone, and increased 1,25-dihydroxyvitamin D (1,25[OH]D) levels. The complete phenotype is
PMID 30765103

Pharmacological management of X-linked hypophosphataemia.

Imel EA, White KE.
British journal of clinical pharmacology. 2019 Jun;85(6)1188-1198.
The most common heritable disorder of renal phosphate wasting, X-linked hypophosphataemia (XLH), was discovered to be caused by inactivating mutations in the phosphate regulating gene with homology to endopeptidases on the X-chromosome (PHEX) gene in 1995. Although the exact molecular mechanisms by
PMID 30207609

Japanese Journal

Hyperemesis gravidarum followed by refeeding syndrome causes electrolyte abnormalities induced rhabdomyolysis and diabetes insipidus

Kondo Tatsuya,Nakamura Miwa,Kawashima Junji,Matsumura Takeshi,Ohba Takashi,Yamaguchi Munekage,Katabuchi Hidetaka,Araki Eiichi
Endocrine Journal 66(3), 253-258, 2019
… A 34-year-old woman with severe HG at 17 weeks of gestation complicated with appetite loss, weight reduction by 17 kg, general fatigue, myalgia, weakness and polyuria was identified to have simultaneous hypophosphatemia (1.6 mg/dL) and hypokalemia (2.0 mEq/L). … Appetite recovery and the improvement of the hypophosphatemia (3.2 mg/dL) were observed prior to the first visit to our department. …
NAID 130007626248

薬学雑誌. 乙号

槇田崇志,白羽英則,田中雄太,西原茂樹,村川公央,北村佳久,岡田裕之,千堂年昭,神崎浩孝,大西秀樹,池田愛璃,高木章乃夫,和田望,竹内康人,安中哲也,池田房雄
薬学雑誌 139(4), 641-645, 2019
… Renal dysfunction, hypophosphatemia, and increased levels of bone alkaline phosphatase were found by a hematology test after admission for treatment of HCC. … After switching from ADV to tenofovir disoproxil fumarate (TDF) and treatment with calcitriol and sodium dihydrogenphosphate, the patient's serum phosphate levels slightly increased and renal dysfunction did not improve, but after six months his clinical symptoms disappeared. …
NAID 130007621633

Hyperemesis gravidarum followed by refeeding syndrome causes electrolyte abnormalities induced rhabdomyolysis and diabetes insipidus

Kondo Tatsuya,Nakamura Miwa,Kawashima Junji,Matsumura Takeshi,Ohba Takashi,Yamaguchi Munekage,Katabuchi Hidetaka,Araki Eiichi
Endocrine Journal, 2019
… A 34-year-old woman with severe HG at 17 weeks of gestation complicated with appetite loss, weight reduction by 17 kg, general fatigue, myalgia, weakness and polyuria was identified to have simultaneous hypophosphatemia (1.6 mg/dL) and hypokalemia (2.0 mEq/L). … Appetite recovery and the improvement of the hypophosphatemia (3.2 mg/dL) were observed prior to the first visit to our department. …
NAID 130007585145